These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3343087)

  • 1. Measles vaccination timing: finding the right age.
    Sieving RE
    Int Nurs Rev; 1988; 35(1):17-21. PubMed ID: 3343087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate age for measles vaccination in the United States.
    Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
    Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles immunity and immunization in developing countries of Africa: a review.
    Abdurrahman MB; Taqi AM
    Afr J Med Med Sci; 1981; 10(1-2):57-62. PubMed ID: 6287828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in east Africa.
    Burström B; Aaby P; Mutie DM
    East Afr Med J; 1995 Mar; 72(3):155-61. PubMed ID: 7796766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal age for measles vaccination.
    Vidyashankar C
    J Indian Med Assoc; 2002 Jan; 100(1):24-6. PubMed ID: 12206338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Persistence of transplacental immunity against measles. Considerations on the importance of the national immunization program].
    Aceves Saínos D
    Salud Publica Mex; 1976; 18(6):973-80. PubMed ID: 1027142
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age.
    Rev Infect Dis; 1983; 5(3):596-605. PubMed ID: 6879022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal age for measles vaccination.
    Mohan M; Sehgal SK
    Indian Pediatr; 1989 Aug; 26(8):739-42. PubMed ID: 2620974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.